Literature DB >> 24061608

Modulating neural plasticity with non-invasive brain stimulation in schizophrenia.

Alkomiet Hasan1, Thomas Wobrock, Tarek Rajji, Berend Malchow, Zafiris J Daskalakis.   

Abstract

Schizophrenia is a severe mental disorder characterised by a complex phenotype including positive, negative, affective and cognitive symptoms. Various theories have been developed to integrate the clinical phenotype into a strong neurobiological framework. One theory describes schizophrenia as a disorder of impaired neural plasticity. Recently, non-invasive brain stimulation techniques have garnered much attention to their ability to modulate plasticity and treat schizophrenia. The aim of this review is to introduce the basic physiological principles of conventional non-invasive brain stimulation techniques and to review the available evidence for schizophrenia. Despite promising evidence for efficacy in a large number of clinical trials, we continue to have a rudimentary understanding of the underlying neurobiology. Additional investigation is required to improve the response rates to non-invasive brain stimulation, to reduce the interindividual variability and to improve the understanding of non-invasive brain stimulation in schizophrenia.

Entities:  

Mesh:

Year:  2013        PMID: 24061608     DOI: 10.1007/s00406-013-0446-8

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  103 in total

Review 1.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

Review 2.  Glutamatergic model psychoses: prediction error, learning, and inference.

Authors:  Philip R Corlett; Garry D Honey; John H Krystal; Paul C Fletcher
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

Review 3.  Transcranial magnetic stimulation: a primer.

Authors:  Mark Hallett
Journal:  Neuron       Date:  2007-07-19       Impact factor: 17.173

4.  Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia.

Authors:  Rodrigo D Paz; Nancy C Andreasen; Sami Z Daoud; Robert Conley; Rosalinda Roberts; Juan Bustillo; Nora I Perrone-Bizzozero
Journal:  Am J Psychiatry       Date:  2006-10       Impact factor: 18.112

5.  Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia.

Authors:  Takanori Hashimoto; H Holly Bazmi; Karoly Mirnics; Qiang Wu; Allan R Sampson; David A Lewis
Journal:  Am J Psychiatry       Date:  2008-02-15       Impact factor: 18.112

6.  Disrupted cortical conductivity in schizophrenia: TMS-EEG study.

Authors:  Marina Frantseva; Jie Cui; Faranak Farzan; Lakshminarayan V Chinta; Jose Luis Perez Velazquez; Zafiris Jeffrey Daskalakis
Journal:  Cereb Cortex       Date:  2012-10-05       Impact factor: 5.357

7.  Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla.

Authors:  Alexa J Stern; Antonina A Savostyanova; Aaron Goldman; Alan S Barnett; Jan Willem C van der Veen; Joseph H Callicott; Venkata S Mattay; Daniel R Weinberger; Stefano Marenco
Journal:  Biol Psychiatry       Date:  2008-08-15       Impact factor: 13.382

8.  Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia.

Authors:  Catarina Freitas; Felipe Fregni; Alvaro Pascual-Leone
Journal:  Schizophr Res       Date:  2009-01-11       Impact factor: 4.939

9.  Dysfunctional neural plasticity in patients with schizophrenia.

Authors:  Zafiris J Daskalakis; Bruce K Christensen; Paul B Fitzgerald; Robert Chen
Journal:  Arch Gen Psychiatry       Date:  2008-04

10.  A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS.

Authors:  Binith Cheeran; Penelope Talelli; Francesco Mori; Giacomo Koch; Antonio Suppa; Mark Edwards; Henry Houlden; Kailash Bhatia; Richard Greenwood; John C Rothwell
Journal:  J Physiol       Date:  2008-10-09       Impact factor: 5.182

View more
  12 in total

1.  Therapeutic targets in major psychiatric disorders revisited.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-12       Impact factor: 5.270

2.  Structural brain changes are associated with response of negative symptoms to prefrontal repetitive transcranial magnetic stimulation in patients with schizophrenia.

Authors:  A Hasan; T Wobrock; B Guse; B Langguth; M Landgrebe; P Eichhammer; E Frank; J Cordes; W Wölwer; F Musso; G Winterer; W Gaebel; G Hajak; C Ohmann; P E Verde; M Rietschel; R Ahmed; W G Honer; P Dechent; B Malchow; M F U Castro; D Dwyer; C Cabral; P M Kreuzer; T B Poeppl; T Schneider-Axmann; P Falkai; N Koutsouleris
Journal:  Mol Psychiatry       Date:  2016-10-11       Impact factor: 15.992

Review 3.  Kraepelin revisited: schizophrenia from degeneration to failed regeneration.

Authors:  P Falkai; M J Rossner; T G Schulze; A Hasan; M M Brzózka; B Malchow; W G Honer; A Schmitt
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

4.  A meta-analysis of the effects of aging on motor cortex neurophysiology assessed by transcranial magnetic stimulation.

Authors:  Apoorva Bhandari; Natasha Radhu; Faranak Farzan; Benoit H Mulsant; Tarek K Rajji; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Clin Neurophysiol       Date:  2016-06-08       Impact factor: 3.708

5.  Smoking restores impaired LTD-like plasticity in schizophrenia: a transcranial direct current stimulation study.

Authors:  Wolfgang Strube; Tilmann Bunse; Michael A Nitsche; Thomas Wobrock; Richard Aborowa; Kristina Misewitsch; Maximiliane Herrmann; Peter Falkai; Alkomiet Hasan
Journal:  Neuropsychopharmacology       Date:  2014-10-13       Impact factor: 7.853

Review 6.  Dysplasticity, metaplasticity, and schizophrenia: Implications for risk, illness, and novel interventions.

Authors:  Matcheri S Keshavan; Urvakhsh Meherwan Mehta; Jaya L Padmanabhan; Jai L Shah
Journal:  Dev Psychopathol       Date:  2015-05

7.  BDNF-Val66Met-polymorphism impact on cortical plasticity in schizophrenia patients: a proof-of-concept study.

Authors:  Wolfgang Strube; Michael A Nitsche; Thomas Wobrock; Tilmann Bunse; Bettina Rein; Maximiliane Herrmann; Andrea Schmitt; Vanessa Nieratschker; Stephanie H Witt; Marcella Rietschel; Peter Falkai; Alkomiet Hasan
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

8.  Parameter-Based Evaluation of Attentional Impairments in Schizophrenia and Their Modulation by Prefrontal Transcranial Direct Current Stimulation.

Authors:  Nadine Gögler; Irina Papazova; Tatiana Oviedo-Salcedo; Nina Filipova; Wolfgang Strube; Johanna Funk; Hermann J Müller; Kathrin Finke; Alkomiet Hasan
Journal:  Front Psychiatry       Date:  2017-11-29       Impact factor: 4.157

Review 9.  Transcranial direct current stimulation in schizophrenia.

Authors:  Sri Mahavir Agarwal; Venkataram Shivakumar; Anushree Bose; Aditi Subramaniam; Hema Nawani; Harleen Chhabra; Sunil V Kalmady; Janardhanan C Narayanaswamy; Ganesan Venkatasubramanian
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-12-24       Impact factor: 2.582

Review 10.  A Review of Impaired Neuroplasticity in Schizophrenia Investigated with Non-invasive Brain Stimulation.

Authors:  Apoorva Bhandari; Daphne Voineskos; Zafiris J Daskalakis; Tarek K Rajji; Daniel M Blumberger
Journal:  Front Psychiatry       Date:  2016-03-29       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.